Saxenda

Medicinal product

(Invented) name

Saxenda

Active substance (s)

Liragliutidas

Strength

6 mg/ml

Pharmaceutical form

injekcinis tirpalas užpildytame švirkštiklyje

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BJ02, liraglutide

Marketing authorisation holder

Novo Nordisk A/S, Danija

Date of authorisation

2015-03-23

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in pre-filled pen	1 ml
Liragliutidas	6 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
61697	76039	1076039	užpildytas švirkštiklis	3 ml N1		Receptinis	EU/1/15/992/001	Netiekiama	-	-	No	-	-
61698	76040	1076040	užpildytas švirkštiklis	3 ml N3		Receptinis	EU/1/15/992/002	Netiekiama	-	-	No	-	-
61699	76041	1076041	užpildytas švirkštiklis	3 ml N5		Receptinis	EU/1/15/992/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2015-03-23	Registruotas